• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Estee Lauder Companies Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    5/23/25 8:02:01 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $EL alert in real time by email
    el-20250522
    00010012506/30false00010012502025-05-222025-05-22


     
     UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ____________________
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported)
    May 22, 2025
     
    The Estée Lauder Companies Inc.
    (Exact name of registrant as specified in its charter)

    Delaware1-1406411-2408943
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
    767 Fifth Avenue, New York, New York
    10153
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code
    212-572-4200

    Not Applicable
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, $.01 par valueELNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    On May 22, 2025, the Board of Directors (the “Board”) of The Estée Lauder Companies Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Amended and Restated Bylaws, effective as of such date. The changes made by the amendment and restatement:

    •revise the procedural mechanics and disclosure requirements relating to business proposals submitted and director nominations made by stockholders, including provisions (i) requiring a stockholder to provide certain information, and make certain representations, to the Company or (ii) pertaining to stockholder solicitations covered by the Securities Exchange Act of 1934, as amended, including pursuant to Rule 14a‑19 (i.e. the universal proxy rule);
    •add a provision for exclusive Delaware forum selection or federal forum selection for certain claims;
    •clarify that indemnification of agents of the Company is permissive instead of mandatory, and remove the standard of conduct requirement for advancement of expenses to directors and officers;
    •remove references to the Executive Chairman position, and add a provision establishing a Chair of the Board;
    •clarify the Board’s ability to appoint alternate members of Board committees; and
    •make certain other updates and conforming, ministerial, or technical changes, including to align with Delaware law.

    The foregoing description does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.2 and is incorporated herein by reference.

    Item 9.01 Financial Statements and Exhibits

    (d) Exhibits. See Exhibit Index below, incorporated herein by reference.

    Exhibit Index
    Exhibit No.Description
    3.2
    The Estée Lauder Companies Inc. Amended and Restated Bylaws
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).


    2




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    THE ESTÉE LAUDER COMPANIES INC.
    Date:May 23, 2025By:/s/ Rashida La Lande
    Rashida La Lande
    Executive Vice President and General Counsel

    3

    Get the next $EL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EL

    DatePrice TargetRatingAnalyst
    5/2/2025$76.00 → $66.00Market Perform
    Telsey Advisory Group
    11/1/2024$105.00 → $76.00Market Perform
    Telsey Advisory Group
    11/1/2024$113.00 → $74.00Overweight → Neutral
    JP Morgan
    10/31/2024$105.00 → $72.00Overweight → Equal Weight
    Wells Fargo
    10/31/2024$105.00 → $80.00Buy → Neutral
    Citigroup
    10/31/2024$125.00Buy → Hold
    Stifel
    10/16/2024$100.00Buy → Hold
    HSBC Securities
    9/10/2024$95.00Neutral
    B. Riley Securities
    More analyst ratings